Morphea and other localized forms of scleroderma
Authors:
- Chelsea SendejoCSChelsea Sendejo
- Heidi JacobeHJHeidi Jacobe
- 1 November 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 24 (6) , 685-693
Abstract
Morphea, also known as localized scleroderma, is a disorder of excessive collagen deposition leading to thickening of the dermis and/or subcutaneous tissues and may cause significant morbidity. This review will describe new developments in the evaluation and management of morphea as well as its pathophysiology. The reader will be able to apply these findings to patient management. The recent development of validated outcome measures (i.e. the localized scleroderma cutaneous assessment tool) as well as consensus treatment recommendations provide a platform for collaboration among specialties to develop both standardized assessment tools and therapeutic trials. New studies have also begun to investigate the immunological underpinnings of morphea. The promise of evidence-based treatments for morphea in the near future will provide better care for patients with morphea and understanding its pathophysiology will lay groundwork for the development of new treatments.Keywords
This publication has 37 references indexed in Scilit:
- Misdiagnosis and delay in referral of children with localized sclerodermaBritish Journal of Dermatology, 2011
- Cytokine profiles in localized scleroderma and relationship to clinical featuresCytokine, 2011
- Clinical features of childhood localized scleroderma in an incidence cohortRheumatology, 2011
- Distinct Autoimmune Syndromes in MorpheaArchives of Dermatology, 2009
- Autoantibodies against matrix metalloproteinase-1 in patients with localized sclerodermaJournal of Dermatological Science, 2008
- Localized scleroderma in childhood is not just a skin diseaseArthritis & Rheumatism, 2005
- Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosisArchives of Dermatological Research, 2004
- Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized sclerodermaArchives of Dermatological Research, 1995
- Immunocytochemical Localization and Serologic Detection of Transforming Growth Factor β1Arthritis & Rheumatism, 1994
- Morphea and lichen sclerosus et atrophicusJournal of the American Academy of Dermatology, 1980